Thursday, September 15, 2016 5:29:22 PM
Nutra Pharma's MS drug is real. The fact that the FDA granted them an Orphan Designation is real. I got excited when they announced Dale Vanderputten joining the company - - because he's real.
Sales would be phenomenal and would certainly increase PPS - but any real value would have to be in the speculation of an eventual blockbuster drug (i.e. MS, RA, etc..). I could even argue that sales de-value a Biotech company because it gives investors something to tack value to instead of the exciting nature of a future drug.
So - let's see some sales, but if these guys can get a Phase II started in MS we could really something.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM